Raphamin is an innovative medication for the treatment of acute respiratory tract infections and prevention of bacterial complications. It exerts both antiviral and antibacterial activity.
Raphamin is a one-of-a-kind medicine that affects the molecules of the major histocompatibility complex (MHC), Class I and II. The MHC molecules are responsible for the recognition of viral and bacterial pathogens and participate in the activation of the immune response. As a result, Raphamin has not only an antiviral but also a moderately pronounced immune-mediated antibacterial effect. In the course of our research, a unique feature of the medication was experimentally proven: when Raphamin is used together with antibacterial medications, the efficacy of the antibiotic is enhanced even in case of initial resistance by pathogenic bacteria.
The developed combination of the Raphamin components is a fundamentally new solution in the treatment of acute respiratory tract infections.
Flat-cylindrical tablets, scored and chamfered, from white to almost white. On the flat side with a risk there is an inscription MATERIA MEDICA, printed on the other flat side RAPHAMIN.
Treatment of acute respiratory viral infections in adult patients.
The notch is not intended for dividing the tablet into parts.
Take orally - not with meals. Keep the tablet in your mouth until
complete dissolution.
On the 1st day of treatment, take 8 tablets according to the following scheme:
1 tablet every 30 minutes for the first 2 hours (for a total of 5 tablets in 2 hours),
then during the same day take another 1 tablet 3 times through
equal intervals of time. On the 2nd day and beyond, take 1 tablet
3 times a day. The duration of treatment is 5 days.
In the absence of a positive effect from the conducted within 5 days
therapy with the drug or worsening of the condition, you should consult a doctor.
